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ABSTRACT 
  Mutations in the TSC2 gene, coding for the tumour suppressor protein 
Tuberin,  lead to formation of benign tumours in systems like the brain. Some data 
supports Tuberin being an essential regulator of neural development and playing 
a  role in cell fate decisions.  
I hypothesized that Tuberin is an essential regulator of neural cell fate 
decisions in the cerebellum and  mutations in  Tuberin may fuel the expansion of a 
stem-like population of cells in the childhood malignant brain cancer 
Medulloblastoma (MB). I found that Tuberin levels were tightly regulated in select 
regions of the brain. Culture of    primary cerebellum stem/progenitor cells was 
performed.  I demonstrated that Tuberin levels are downregulated throughout cell 
differentiation. Tuberin levels are high in the stem-like population in MB 
cells.  This supports that Tuberin is an essential regulator of differentiation  in 
stem-like progenitor population. Coaxing this stem-cell population to undergo 
functional differentiation in MB is one potentially exciting area for new cancer 
therapy. 
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INTRODUCTION 
 
I. Tuberin: A Tumour Suppressor 
 
It is crucial to maintain cellular homeostasis within a growing population of cells in the 
body. The process of cellular growth involves a series of controlled and regulated divisions. 
There are many different factors that keep the process of cellular growth and cellular death in 
balance. Genes that achieve this purpose are called tumour suppressor genes. A tumour 
suppressor gene is mainly defined as an anti-oncogene; thereby, preventing cells from becoming 
cancerous
1
. Generally, a tumour suppressor gene hinders cell proliferation and slows down the 
cell cycle. Mutations that lead to uncontrolled cell growth, which with further cooperating 
mutations, can lead to cancer formation 
1
. 
For tumour suppressor genes to lose their inhibitory function, the requirements for the 
“two hit hypothesis” must be met. Established by Alfred Knudson, the “two hit hypothesis” 
proposes that tumour suppressor genes must lose both functional copies to contribute to the 
oncogenic process
2,3
. The first mutation that occurs would result in a germ line mutation which 
would then be passed on to the somatic cells of the embryo. During mitosis, another mutation, a 
“second hit”, occurs in a single cell. If these somatic mutations accumulate, an abrogation in the 
tumour suppressor gene will occur
3,4
. Knudson came upon this discovery when studying 
Retinoblastoma cells where he found that in a sporadic Retinoblastoma, if the two alleles are 
wild type then two mutations will be required to cause disease. On the other hand, if the alleles 
were heterozygous, then one mutation will be required to result in disease formation
3,4
. The gene 
byproducts of tumour suppressors can be affected when the suppressor’s function is abrogated.  
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A key pathway  that regulates cellular growth and proliferation is the Mammalian Target 
of Rapamycin (mTOR)
5,6
. One of the upstream regulators of mTOR is a heterodimer complex 
called the Tuberous Sclerosis Complex (TSC). This heterodimer is made up of Tuberin, encoded 
by the gene TSC2 and Hamartin encoded by the TSC1 gene
6,7
. Mutations that occur in these 
tumour suppressor genes can lead to tumour formation. An example that has been well studied is 
the disease Tuberous Sclerosis (TS). This disease is usually passed on by genetic inheritance 
through parents that possess germ cell mutations. The transmission of TS can happen through 
spontaneous genetic mutations called de novo mutations. Such spontaneous mutations occur 
more frequently. Statistically, 60-70% of patients do not exhibit any genetic inheritance from 
sporadically caused  mutations
7
. Under circumstances where there is  heterozygous inactivation 
in either genes, TSC1 or TSC2, it will be inadequate to cause severe disease phenotypes in 
patients
7
. Conversely, it is imperative that second hit somatic mutations are behind serious 
disease manifestation to arise. These mutations depict Knudson’s Tumour Suppressor model2,8. 
While the protein products of these genes work together it is known that mutations in the TSC2 
gene are more frequent and result in more severe phenotypes than mutations occurring in the 
TSC1 gene
9
.  
The TSC2 gene is situated on chromosome 16p13.3 and constitutes of 42 exons overall 
and 41 of them code for the protein, Tuberin
8
. TSC1 is found on chromosome 9q34 and 
constitutes 23 exons 
8,10
. The protein Tuberin has a molecular mass of 200 kDa, Hamartin is 
smaller with a molecular mass of 130 kDa. Interestingly, the molecular mass of the TSC is 
roughly 450 kDa which is bigger than Tuberin and Hamartin forming independently, implying 
the presence of additional members of the complex are yet to be identified
11,12
. The TSC is 
formed through  Hamartin interacting with Tuberin at the N-terminus (Figure 1). Hamartin and 
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Tuberin interactions function to support and stabilize Tuberin by preventing Tuberin’s 
degradation by HERC1 ubiquitin ligase
13,11
. The primary characterized functional domain of 
Tuberin is the GTPase activating protein (GAP) domain residing in the C-terminal portion of the 
protein.  Tuberin GAP function is directed toward the GTP binding protein Ras homolog 
enriched in the brain (Rheb), which itself has GTPase activity and is responsible for negatively 
regulating mTOR.  
 
 
 
 
 
 
 
Figure 1. Tuberin Structure Showing the Functional Domains   
Highlighted with a red box at amino acid (aa) 1-418 is the Hamartin binding domain, at aa 1101-
1320 is the 14-3-3 binding region and the functional GAP domain is indicated at aa 1517-1672. 
Two coiled-coil (cc) domains, a leucine zipper (LZ), and a calmodulin binding region (CaM) are 
indicated as boxes on the diagram itself.  Phosphorylation sites are indicated by a P with either 
an inhibitory or activating modification and the primary kinase indicated above. Adapted from 
Rosner et al. 2008
8
.
12
 
 
II. TSC and mTOR Signalling 
Tuberin and Hamartin are indispensible tumour suppressor proteins needed in controlling 
cellular growth via the mTOR pathway
6
. Tuberin function is largely affected by post-
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translational modifications occurring via nutrient signaling such as growth factors (ERK) and 
insulin (PI3K/Akt) and direct sensing of ATP levels (AMPK)
14,15
 (Figure 1). These signals are 
then transmitted specifically to the downstream  effector  mTOR or directly to the cell cycle 
machinery to regulate cell size, proliferation, and protein synthesis
6
 (Figure 2).  
 
Figure 2: mTOR Pathway 
Cartoon depicting the links between the TSC (Tuberin and Hamartin) with the mTOR 
pathway and cell cycle regulation. Upstream signaling from the insulin growth factor 
receptor (IGF) is one representative feed from a nutrient pathway.  
 
mTOR is a large protein and has a molecular mass of 289 kDa and belongs to the 
superfamily phosphatidylinositol kinase-related kinase (PIKK)
16
. Based on research conducted 
on yeast, Saccharomyces cerevisiae, the Target of Rapamycin (TOR) was discovered. TOR1 and 
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TOR2 are the two major genes that form the TOR proteins. Researchers concurred that these two 
genes have been known for their Rapamycin sensitivity; however, recent research has 
demonstrated that TOR2 possesses Rapamycin insensitivity features. Being  insensitive to the 
drug, Rapamycin, TOR2 acts as a roadblock  in decreasing TS  symptoms
17
. In mTORC1, 
mLST8 can bind to mTOR to facilitate its kinase activity. Also, mTOR can bind with rictor 
(Rapamycin insensitive), and associate with SIN1 and mLST8 to form  mTORC2 and preserve 
its integrity
17
.
12
   
mTOR is the downstream effector of PI3K/Akt signal transduction pathway. This pathway is 
initiated when ligands or hormones bind to the IGF receptor on the cell membrane surface. Once 
binding of the ligand to the receptor takes place, phosphorylation of PI3K instigates a regulation 
cascade that creates a positive feedback loop amongst all the elements in the pathway
6
. If mTOR 
is misregulated due to the mutation in TSC2 or TSC1, certain acute phenotypic manifestations 
will be visible and diseases become dominant. Amongst these diseases are: Tuberous Sclerosis, 
autism, and Alzheimer’s disease, etc.8. 12  
Tuberin also directly regulates the cell cycle by enhancing the functional activity of p27, a 
cyclin-dependent kinase (CDK) inhibitor. Previous studies had shown that Tuberin expression 
levels in cells have a huge impact on the cytoplasmic or nuclear localization of p27
7
. This 
suggests that the CDK inhibitor,  p27,  works as a tumour suppressor by inhibiting CDK activity
7
 
,12
.  Tuberin is also capable of regulating mitotic onset binding directly to the mitotic cyclin, 
Cyclin B1, and controlling the timing of the nuclear transport of the protein, a fundamental step 
that triggers mitosis
18
. Collectively, Tuberin functions as a pivotal mechanism of translating 
information about the nutrient status in a cell. When energy levels are low, Tuberin is regulated 
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and inhibits growth and proliferation. Conversely, Tuberin is inactivated in situations of high 
nutrient levels to permit growth and cell division
18
.   
 
III. Brain Development and Neurogenesis  
Brain development. 
 The first stage of embryonic development from a blastula is gastrulation, or the 
reorganization of cells into the three germ layers; ectoderm, mesoderm, and endoderm
19,20,21
. 
Gastrulation is followed by organogenesis which is a stage initiated by the development of the 
neural tube which is the structure from which the CNS originates
21
.  Neural tube formation is 
elicited by signals from a structure that arises from the mesoderm called the notochord
21
. The 
CNS and the brain arise from the ectoderm
20,21
. Environmental signals inhibit neural specific 
tissues from becoming other ectoderm structures such as the epidermis. Two critical signaling 
pathways that dictate patterning of the neural plate, which acts as the foundation of the CNS and 
arises from the ectoderm, are the Wnt pathway, responsible for CNS patterning, and the Bone 
Morphogenic Protein (BMP) pathway
22
. During neurulation the cells located around the neural 
plate undergo invagination and folding to form the neural tube
22
. The neural tube is characterized 
by polarization alongside the ventral-dorsal axis
23
. The spinal neurons exist in the dorsal area of 
the neural tube whereas the motor neurons are located in the ventral area where they receive 
external signals
19,23
. The ventral pattern and dorsal pattern are induced by the notochord and 
epidermis, respectively
23
. This patterning is critical for dictating the continued development of 
the CNS as a whole and forming the spinal cord and the brain. 
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Neurogenesis.   
Neurogenesis is the cell biology process by which different neural structures are formed 
through the production of neurons and glial cells from a neural stem cell and underlying 
progenitor cells
24,19
. The development of the human brain begins at the third week of gestation
25
. 
However cell fate, or the concept of what the cells will become, is partly determined by the 
polarity of the neural stem cell and the position by which it lies in the developing embryo. One 
of the key processes in neural development is the process of neural induction that occurs at the 
blastula stage. Throughout neural induction, cells found in the embryonic ectoderm are instigated 
to differentiate and to specialize into cells that contribute to the overall formation of the CNS
19,26
. 
Neural induction sets the stage for cells to take specific routes in response to external signals. 
Throughout the developmental process the stem and progenitor cells will receive cues from the 
changing environment to guide the differentiation decisions determining the number and type of 
neural cells formed
19
. The two routes that cells can differentiate into are glial cells or neuronal 
precursor cells. As the cell fate decision is being made, the cells become committed to a certain 
type of cell which down the road will be differentiated into a neuron or a mature glial cell type
26
. 
The events that take place while the embryo is still developing are quite important due to the fact 
that critical CNS structures are formed at the end of that period
25
.  
The population of cells located in the wall of the developing neural tube, are 
neuroepithelial cells which ultimately differentiate into different cell types such as neurons and 
glial cells. As the process of neurogenesis proceeds, the cells within the neural tube undergo a 
series of events that involves reorganization and rearrangement of the cells within the neural 
tube
27,23
. This series of rearrangements allows the population of proliferating progenitor cells to 
go through neural divisions either symmetrically or asymmetrically
28
.  It is crucial that the 
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process of neural tube formation does not go wrong because any defects in this process will 
cause neurological defects in the embryo such as Spina Bifida
29
. 1 in 2000 newborns experience 
neural tube defects in the US
29
. Patterning of the neural tube is a result of environmental signals 
that are secreted by certain molecules
19,23,30
. The ventral axis patterning is governed by Sonic 
Hedgehog signaling which eventually leads to the expression of transcription factors that give 
neural progenitor cells their integrity
31
. On the other hand, BMP and Wnt signaling pathways 
govern the patterning of the dorsal region of the neural tube
27,23,32
. All in all, neurogenesis is a 
crucial process throughout mammalian brain development. Furthermore, the activity of 
neurogenesis is higher in regions of the brain like the cerebellum which regulates motor 
control
33
.  
Implications of Tuberin in neural development.  
While not well-understood, Tuberin has been implicated in development. Floricel et al. have 
conducted experiments that show when TSC2 is mutated in vivo, neurological development 
especially in the brain is negatively affected
34
. They found that neurite outgrowth was inhibited 
within the PC12 cell line
34
. Additionally, in a separate study by Choi et. al., they demonstrated 
that axons that formed were disordered. This was mainly observed when TSC2 or TSC1 were 
knocked down. In the absence of TSC2 or TSC1, axonal outgrowth increased in the cells. Under 
conditions where these genes were overexpressed, axon formation was repressed
35
. Furthermore, 
it has been demonstrated that the knockdown of TSC2 or TSC1 led to an increase in the size of 
cells in the postmitotic neurons and dendritic spines
36
. Collectively, these findings imply the 
intriguing possibility that Tuberin is important in the process of neural cell fate decisions. 
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IV. A Brief Overview of Cerebellum Development 
The cerebellum is a brain structure situated in the hindbrain specifically in the anterior 
region
37
. It is responsible for regulating sensory-motor processes
37
. Of the vast majority of 
neurons that make up the brain, about half of them are located in the cerebellum
37,38
. The 
rudimentary structures of the cerebellum start forming at six weeks of embryonic development 
within the human brain. CNS development begins very early in embryogenesis and it is the last 
process to be completed after birth. On average, the brain is fully developed at 20 years of age. 
In the cerebellum there is a heterogenous population of neurons. Pre-cerebellar neurons are 
neurons found in the rhombic lip of the hind brain
39
. Through the process of nucleokinesis, these 
cells migrate to designated places of the cerebellum by allowing their nucleus to move
39,40
. 
Through several different processes of chemotactic agents, the movement of these cells is 
guided
39
.  
There are several layers of neuronal cells that make up the cerebellum and migrate to 
designated locations termed the nuclear layer and the molecular layer
41
 (Figure 3). The 
molecular layer is composed of Purkinje cells that are found between compact granule cells and 
Purkinje cell dendrites
41
. The Purkinje cells are a group of the largest inhibitory GABAergic 
neurons that process inhibitory information relayed to them by granule cell fibers. Granule cells 
are located in the granular layer and they are classified as excitatory glutamatergic neurons. They 
process inhibitory information received from Golgi neurons. Granule cells form axons that 
penetrate to the molecular layer and make connections with dendrites of the Purkinje cells
42
. 
Granule cell precursors usually reside in the External Germinal Layer (EGL) where they later 
migrate from the rhombic lip to the pial surface during development. The EGL disappears when 
the cerebellum is fully developed and the granule cells are found within the IGL
43
. 
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Figure 3. Illustration Depicting the Neuronal Cells that Make up the Cerebellum 
Within the cerebellum, the neuronal cells reside in various layers such as the granule cell 
layer, purkinje cell layer, and the molecular layer. Adapted from Tabata et al.
44
 
 
V. Stem Cells Have Distinctive Properties 
 
A stem cell is present at various stages during development. It is an undifferentiated cell 
that has the potential to differentiate or develop into different types of cells, tissues, and organs 
in the body
45
. The stem cell population both creates an initial structure and it works as an internal 
repair mechanism in the body by continuously dividing and replenishing damaged cells
46
. There 
are two ways in which cells can divide; asymmetric cell division and symmetric cell division
47,48
. 
In asymmetric cell division, the parent stem cell divides into two daughter cells one of which is a 
stem cell while the other is a non-stem cell that has the potential to specialize and differentiate 
into a specific cell type such as a brain cell, or blood cell, etc. In a symmetric cell division, the 
parent stem cell produces two new stem cells
48,49,50
. (Figure 4).  
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Figure 4. Mechanisms of Stem Cell Division
50
 
Illustration depicting the two different models of stem cell division. Stem cells can divide 
asymmetrically, producing a daughter cell that is differentiated and another that is a stem cell. In 
symmetric cell division the daughter cells produced are identical to the original parent cell. 
Adapted from Shahrayari et. al. 2013. 
 
In the asymmetric division model, it is believed that homeostasis is controlled at a single 
cell level by having the parent cell produce one stem cell and one differentiated cell
48,51,46
. One 
problem that arises from the asymmetric division model is that in case of damage or injury, the 
stem cell pool may exhaust the ability to self-renew. This problem is solved by the presence of 
symmetric cell division model which controls and maintains homeostasis at a cell population 
level as compared to a single cell level
46
.  
The symmetric division model involves two different types of division which includes a 
proliferation division and a differentiation division
50,46
. As mentioned above, proliferation leads 
to the formation of two stem cells while differentiation gives rise to two differentiated 
specialized cells from unspecialized progenitors
46
. The proliferation or differentiation division is 
determined by certain signals or quos that are received by the stem cells from the surrounding 
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environment. Proliferation and differentiation decisions must be controlled in order to maintain 
homeostasis and balance control
46
. If these decisions are not controlled, stem cell expansion will 
be tipped off balance. In addition, abnormal control of asymmetric division may lead to 
formation of cancerous tumours due to build up of undifferentiated cells
46,47
. The main role of 
stem cells in tissue is to maintain homeostasis through its major properties; differentiation and 
self-renewal. Disease can be a serious result of fluctuations in the balance of such stem cell 
populations
50
.  
To classify a cell as “stem” cell, it must possess the two important stem cell 
characteristics. The first characteristic is that the cell is unspecialized
45
. This feature means that 
these cells are able to continuously divide and self-renew
52
. The second feature of stem cells is 
that they are able to become committed and specialize into specific types of cells under certain 
situations physiologically and experimentally
52, 45
.  
Stem cells are divided into two main classes; embryonic stem cells as well as adult stem 
cells
45
. An embryonic stem cell forms when the fertilized egg divides. These cells are present in 
humans at the first 3-5 days of development at the blastocyst stage
45
. Cells at this stage are the 
ones necessary to give rise to the organism as a whole. Adult stem cells are those that are found 
in already developed tissues
45,48
. The main task of these cells is to repair damaged tissue. Adult 
stem cells work to replenish specialized cells that are dead
46
. The brain, bone marrow, blood, 
muscle, and skin, are the tissues with the most work done on adult stem cells
45,46
. 
The existence of adult neural stem cells was a topic of much debate until a finding by 
Nottebohm demonstrated that neurogenesis exists in the adult brain of vertebrates
53
. Neural stem 
cells are stem cells that are found within the CNS which possess the ability of self renewal
54
. 
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Mammalian neural stem cells were first isolated by Reynolds and Weiss in 1992
55
. In their 
studies, Reynolds and Weis investigated whether cells isolated from the stratium and grown in 
culture were able to proliferate and divide in the absence of the epidermal grow factor (EGF). 
These researchers have concluded that in order to promote the growth and proliferation of 
isolated cells either from an adult or embryonic mouse brain sample, EGF is required. EGF 
allows for the formation of free floating spheres which were eventually called “neurospheres”.  
Neurospheres are composed mainly of glia and neuron cells
55
. These spheres also express the 
neural stem cell marker, Nestin
56
. Reynolds et al. have also confirmed the stem cell identity of 
the neurospheres by conducting experiments demonstrating that a neurosphere can form from a 
single cell even when the neurospheres are dissociated
55
. This neural cell isolation was achieved 
by building on information and discoveries made previously in 1983 by a group of researchers. 
Raff and colleagues discovered a type of cell that has the capacity to differentiate into a fibrous 
astrocyte and an oligodendrocyte
57
. This cell was derived from the optic nerve of a rat that was 7 
days old. Their findings suggested that from a single glial progenitor cell in vitro, two different 
types of cells were able to form
57
. Being able to isolate neural stem cells and producing other cell 
types in culture can aid in contributing to finding a cure in patients suffering from neurological 
disorders. 
Since the discovery by Reynolds and Weiss, many researchers have begun studying 
mammalian adult neural stem cells. In 1993, Luskin and colleagues were able to report that cells 
in the adult subventricular zone (SVZ), exhibited continuous proliferation which in turn led to 
the production of neurons in the olfactory bulb
58
. This suggests that within the SVZ there is a 
population of neural progenitor cells that is continuously proliferating. Furthermore, the 
ependymal region of the brain has also been shown to possess characteristics of neural cells. 
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Researchers have proved that ependymal cells are stem cells because they elicit neuron 
production when the CNS is exposed to injury
53
.  
The first neural stem cell extraction conditions characterized neurosphere assay as a 
method of culturing and retaining stem cell characteristics
55
. This assay also began to teach a lot 
about the conditions that maintain stemness in the brain as the neurospheres must be provided 
with specific media and given necessary growth supplements
55
. For neural stem cells fibroblast 
growth factor (FGF) and EGF are important in maintaining stemness. In addition, the nerve 
growth factor (NGF) is needed to aid in producing neurons
55. With today’s technology and 
laboratory techniques cells can be extracted and cultured from nearly any region of the adult 
vertebrate brain.  
Among the different factors like FGF and EGF that have proven important in dictating 
the stemness of the neural stem cell population, the Notch pathway plays a role in regulating cell 
fate decisions and cell self-renewal
59
. The Notch pathway is highly conserved and involved in 
important cellular decisions such as proliferation and differentiation especially during 
embryogenesis and CNS formation
59,60
. In the brain, the neural progenitor cell population is 
sustained through the Notch pathway
59
. This pathway is composed of 4 protein homologues; 
Notch1, Notch2, Notch3, and Notch4 that interact with the Notch receptor along with other 
ligands that start a cascade of proteolytic cleavage events that result in Notch translocation into 
the nucleus of the cell where interactions with downstream effectors begins to control the cell 
proliferation, differentiation, and cell fate decisions
59,60
. Tuberin is involved in the Notch 
pathway as an upstream effector
61
. In a study conducted by Ma et. al. in 2010, it was shown that 
the mTOR pathway can be linked to an upregulation of the Notch pathway
61,62
. Some of their 
findings revealed that when mTOR activity is increased, cell differentiation was impeded. To 
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support the fact that when mTOR is hyperactive it leads to Notch upregulation, they proved that 
in mouse embryonic fibroblasts (MEFs) with hyperactive mTOR, Jagged1, the Notch ligand, was 
also found at increasing levels
61
. Furthermore, experiments performed to inhibit the Notch 
pathway were found to abolish tumour formation in the cells where mTOR was active
61
.  
Studying stem cells and their ability to differentiate into specific cell types is critical. 
Stem cells can provide scientists with some insight into how to cure certain diseases by 
investigating how these cells contribute to development. Overtime, research findings can 
contribute to curing diseases such as diabetes, neurological diseases, burns, etc. Studying stem 
cells can provide limitless opportunities for healing disease.  
VI. Brain Tumours and the Cancer Stem Cell Model  
The cancer stem cell (CSC) hierarchal model proposes that a subpopulation of cells existing 
in the tumour cell mass is capable of driving tumour progression. As a result of the cells’ ability 
to self-renew and differentiate, this subpopulation of cells leads to the regeneration of the cancer 
causing cells leading to tumourigenesis
63,64
. On the other hand, the stochastic tumour model 
hypothesizes that within a tumour, all the cells possess tumorigenic properties or can be 
transformed to become tumorigenic
64,65
. There is evidence to support that both models may exist, 
and indeed some cases where combinations of the two may co-occur, but certainly there is strong 
evidence to support that some tumours arise only from a distinct population of cells that possess 
stem cell properties
63,65. Some researchers refer to these cells as ‘tumour-initiating cells (TIC)’ 
while others continue to use the more controversial CSC term. These TIC/CSCs have certain 
properties which include self-renewal and differentiation into specific tissue cells
66, 64
. In 1994, 
John Dick, a Canadian researcher, was one of the first scientists to discover the presence of CSCs 
in certain leukemia models. In his study, he demonstrated using severe combined 
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immunodeficient mouse model, that cancer cells isolated using cell surface markers that express 
a CD34
+ 
CD38
-
, were able to form tumours when introduced into the mice blood system. These 
tumours were representative of the tumour heterogeneity seen in patients with acute myeloid 
leukemia
67
. 
 CSCs can lead to the formation of aggressive malignant tumours in the brain. One form 
of cancer that follows this model is glioblastoma multiforme (GBM). These tumours generally 
originate from neural stem cells located within the brain
68,69
. GBM usually occurs as a result of a 
multitude of mutations and can occur both during childhood and during adulthood. The diversity 
of mutations in this tumour makes the cancer causing cells a challenge to target with 
chemotherapy
70,71,72
. It is believed that the neural stem cells that are the origin of this tumour are 
located in the SVZ of the brain. In previous studies, cancer cells were isolated from the tumours 
in GBM
71
. These tumour cells were able to self renew and produce more tumours which makes 
this disease a recurrent disease even when exposed to conventional therapy
72
.  
VII. Medulloblastoma: Childhood Cancer 
 
 Medulloblastoma (MB) is the most common fast-growing neuroectodermal pediatric 
malignant brain tumours and is the number one cause of mortality in children diagnosed with 
brain cancer
73,74
. According to the American Brain Tumor Association, 400 patients are 
diagnosed with MB each year with the majority of patients being children up to 10 years of 
age
74
. Some of the symptoms that are associated with Medulloblastoma are; lack of co-ordination 
and balance, vomiting, headaches, behavioural changes, and double vision
73,74
. Some treatments 
have been developed to alleviate these symptoms in young children
73,74
. 
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 One of the most effective ways to manage tumours is tissue re-sectioning through surgery 
and the removal of the tumour mass
73,74,75
. Although surgery aims at removing most of the 
cancerous mass, there is a high risk of recurrence through the cerebral spinal fluid (CSF)
75,76
. 
The CSF is one of the pathways through which tumour cells can spread; therefore, it is important 
to keep track of the nature of the cells that are found in the CSF
76
. Chemotherapy and radiation 
that target the brain and spinal cord are standard of care and can shrink the tumour mass but are 
currently not curative.  
VIII. MB Neuropathology: 
 MB is classified as a Primitive Neuroectodermal Tumour (PNET)
77,78
. These embryonal 
tumours are characterized by immature and undifferentiated neural tissue
78
. MB tumours are 
found in the cerebellum and the cell of origin is believed to be granule neuron precursors 
(CGNPs) located in the EGL
78,79,73,77
. The EGL is naturally composed of different types of cells 
mainly including precursor cells. To make it up to the external layer of the cerebellum, these 
cells migrate to the surface. Once they reach the surface of the cerebellum, the cells differentiate 
by going through cell division stages
78
. To form the granular layer, the neurons move inwards. In 
humans, the EGL, remains present in the cerebellum until 2 years of age
78,42
. The purkinje cells 
as well as the cerebellar nuclei arise from the subependymal matrix around the fourth ventricle. 
MB tumours are solid and distinctive
78
. Histologically, cells appear oval and small with little 
cytoplasmic to nuclear ratio
78
. In a study focusing on 21 MB patients, the differentiation capacity 
of the cells from 20 samples that were categorized under classic MB, were studied using glial 
fibrillary acidic protein (GFAP), neurofilaments (NF), S-100 protein (S-100P), and neuron 
specific enolase (NSE)
80
. The findings from this study showed that the majority of the cells were 
positive for NSE which is a nonspecific marker for embryonic cells, neuroblasts
80
. This suggests 
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that neuroglial cells within the MB tumour are actually undergoing differentiation
80
. The tumour 
cells are heterogeneous and may contain differentiated cells where the majority is expected to be 
undifferentiated. 
Generally, MB emerges due to genetic mutations that occur in the pathways that are 
involved in cerebellum formation which lead to developing tumour cells from stem cells. In 
2011, a group of researchers studied primary MB samples. Using techniques such as genome 
profiling in combination with bioinformatics approach, scientists were able to divide MB into 
four distinct subgroups based on several factors. These factors and categorization was based on 
the metastatic status of the tumour, DNA copy number aberrations, and histology
81
. 
Classification of the tumors was also based on age groups. MB is categorized into four different 
subgroups; WNT, Sonic Hedgehog (SHH), Group 3, and Group 4
81
. Classifying MB into the four 
different subgroups allows researchers to investigate specific characteristics of cells in each 
subtype and propose several targeted therapies particular to each subtype. To date, the WNT and 
SHH pathways are more heavily and well studied compared to Group 3 and Group 4 
subtypes
81,82,83
.  
MB categorized into the WNT subgroup, is a rarely occurring tumor
75,83,84
. The Wnt 
pathway is an essential pathway that is activated during embryogenesis
75,84
. During development 
Wnt acts to regulate extremely important processes such as cell fate, embryo patterning, 
proliferation and cell growth. Protein interactions in the Wnt pathway are essential for tightly 
regulated cell to cell communication. Wnt misregulation or mutations are implicated in diseases 
such as cancer
75
. Studying what genetic mutations can lead to Wnt malfunction can be 
implicated in stem cell fate. The primary receptors found in the Wnt pathway are Frizzled (Fz) 
and LRP 
84
. In a normal cell, Wnt signalling is usually inactive, a destruction complex made up 
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of Axin and APC secure the transcriptional regulator β-catenin and target it for ubiquitination 
and proteolytic degradation. Wnt pathway is activated when a Wnt ligand binds to Fz and LRP, a 
membrane receptor
84,
. The binding processes induces the activation of Dishevelled (Dsh) which 
leads to the disintegration of the destruction complex causing β-catenin levels to increase in the 
cytosol and nucleus. When high levels of β-catenin are present, β-catenin accumulates in the 
cytosol and the nucleus as a result of the lack of degradation by proteosomes
84,85
. In the nucleus, 
β-catenin binds to the TCF/LEF transcription factor thereby changing the role that TCF/ LEF 
transcription factor plays as a repressor. Conversely, TCF/ LEF transcription factor activates 
RNA polymerase that prompts gene transcription. A malfunction in this system that 
inappropriately activates the Wnt pathway by a Wnt signal can lead to a mutation in one of the 
few genes that form the destruction complex
84,86
.  
Another MB subtype is driven by the Shh pathway
75,82
. SHH is the gene that encodes for 
the protein Shh, a morphogen
75
. The Shh pathway is inactivated by the receptor Patched (Ptch) 
and in turn Smoothened (Smo), the signaling receptor, gets suppressed by Ptch, thereby 
inhibiting the transcription factor, Gli and the downstream signaling cascade
75,87
. When the Shh 
ligand is present it binds to Ptch at the cell surface which leads to its degradation of Ptch
75,87
. 
This results in Smo moving from the intracellular vesicle to the cell surface to initiate Shh 
signaling and Gli gets activated which can then regulate gene expression
75,88,87
. Historically, the 
hedgehog gene was identified in 1980 in Drosophila melanogaster embryo
89
. Researchers 
performed genetic screening to identify embryonic lethal loci in Drosophila
89
. They looked for 
genes that are mutated and influence the segment polarity. One of those genes was the one that 
encodes for Shh. Shh is responsible for establishing the patterning during embryonic 
development
89
. It is important in creating the midline of the spinal cord, the brain, and the overall 
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body pattern etc
75,89
. In addition Shh is essential for the development of the CNS as a whole
90
. It 
follows that mutations in SHH, can lead to severe neurological diseases and congenital defects 
such as holoprosencephaly (HPE) which results due to an aberration in Shh and incapability of 
the two brain hemispheres and the eyes to develop normally
90
.  
Shh affects signaling in the neural precursor cells (CGNPs) which are believed to be the 
cells of origin of the childhood cancer MB
91
. Interestingly, mutations in TSC2 can cooperate with 
the Shh pathway to lead to formation of cancerous tumours
88
. In a study performed by Bhatia et 
al. in 2009, researchers used a transgenic mouse model that was dominant negative for TSC2 
(TSC2-RGΔ)88.  The lack of Tuberin resulted in aberrant proliferation of CGNPs as well as 
cellular growth was increased indicating abnormalities in cerebellar development. Importantly, 
the TSC2-null/transgenic mouse model had enhanced susceptibility to the initiation of SHH 
subtype of MB. Characterization demonstrated that there was an increased number of neural 
precursor cells along with an increase in mTOR signaling and an inhibition of p27 and GSK3α/β 
activity 
75,88
.  
IX. Hypothesis and Objectives 
I hypothesize that Tuberin protein levels will vary throughout the brain, with levels and 
activity being higher in regions of peak neurogenesis activity. Tuberin is crucial for brain 
development and neural cell differentiation. The tumour suppressor protein, Tuberin, halts 
the cell cycle to allow for asymmetric division and differentiation of cells; therefore, I 
hypothesize that Tuberin levels are lower in differentiating cells as compared to progenitor 
cells and it serves to regulate stem cell differentiation. It is important to determine the normal 
role of Tuberin in neural cell fate; proliferation and differentiation during early development. 
In addition, I hypothesize that Tuberin plays a critical role in the self-renewal of CSC 
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populations within MB.  
Objectives:  
1. Determine Tuberin Protein Levels During Early Brain Development 
Immunohistochemistry DAB staining will be performed on specific brain regions critical 
for neurological development, such as the choroid plexus and the purkinje cell layer, and 
Tuberin protein levels will be quantified and compared at ED 14.5 and ED 16.5. 
2. Identify the Importance of Tuberin During Cerebellum Formation and Cell Fate 
Determination using Primary Cerebellum Cells 
I will optimize the isolation, culturing and differentiation of primary cerebellum cells 
from Balb/C mouse. I will measure changes in Tuberin mRNA through differentiation 
and optimize neurosphere experiments to begin to determine the importance of Tuberin in 
neural stem cell decisions in the cerebellum.  
3. Elucidate the Role of Tuberin in MB CSC Population.  
Tuberin levels will be manipulated in a MB cell line and properties of the CSC 
population studied using neurosphere assays and cell surface markers using flow 
cytometry.  
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MATERIALS AND METHODS 
I. Animals and Breeding 
BALB/c mice (Stock number 000651), were purchased from Charles River Laboratories. The 
mice were kept in the animal care facility at University of Windsor. The experimental procedures 
set by the University of Windsor animal care committee were followed as directed in AUPP # 
12-18. BALB/c mice were bred in the animal care facility and the F1 generation was obtained. 
Mice were euthanized at embryonic day (ED) 14.5 and 16.5 using the CO2 asphyxiation 
chamber.  
All BALB/c mice were housed in the same animal care facility room. Mice were maintained 
under a 12 hour light 12 hour dark cycle. Female mice were placed in cages separate from the 
male mice. To increase the chances of the female’s pregnancy, mouse shavings from the 
female’s cage were introduced into the male’s cage a day before the scheduled breeding date. For 
embryonic time points females were separated and checked for a copulatory plug the next 
morning; denoting day 0 of pregnancy.  
To acquire postnatal brain samples, the mice were kept together for three nights to ensure the 
chances of successful breeding. The gestation period for the mice was about 21 days. The mice 
were checked and monitored throughout the 21 gestation days. Once the pups were born, that 
day was assigned to be postnatal day 1
92
. 
II. Tissue Samples Dissection and Fixation  
Mice were sacrificed in the most humane way possible to obtain samples. For postnatal 
samples, mice were placed in a CO2 chamber for euthanasia. The CO2 cylinder is set to 4 psi. 
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The mice were left in the chamber for 3-6 minutes as per the guidelines from the University of 
Windsor Animal Care and Use Committee, AUPP#12-18.  
Prenatal brain samples were obtained by extraction of the embryos following euthanization 
of the mother. For both embryonic and postnatal brain samples, the brain was placed in 4% 
paraformaldehyde PFA solution overnight. Extra embryonic tissues were then removed and 
embryos were placed in a fresh PFA solution for another night or until the expected tissue 
rigidity was achieved. Sequentially, the samples are moved through a sucrose gradient starting 
with a 20% sucrose gradient (200 mL High Purity Water and 40g sucrose) moving up to 30% 
sucrose gradient (200mL High Purity Water 60g sucrose). The tissue was left in each gradient 
overnight at 4
◦
C. Once one observes that the brains sunk to the bottom of the tube, the gradient 
could be changed and the brains are cryoprotected. 
III. Tissue Sectioning  
The heads were submerged in Shandon M-1 Embedding Matrix (Thermo Electron Corp.; 
#1310) and then placed in a vacuum for 20 minutes at 10mmHg for fixation purposes. The tissue 
in matrix was then frozen at -20
◦
C for about 30 minutes and at a temperature of -18
◦
C. Brain 
tissue was sectioned at 30 μm in the sagittal plane under cold/ freezing conditions using a 
cryostat (Leica cm3050s). For the postnatal time points, the brain was sectioned in the sagittal 
plane at 18 μm thickness. Sections were mounted using permount mounting media (Fischer 
Chemicals; #SP15-100) onto Superfrost Plus slides and stored at -80
◦
C.   
IV. Immunohistochemistry (IHC): DAB Staining 
Slides containing tissue sections were left at room temperature for 10 minutes to ensure the 
tissue adhered properly to the slide. The slides were then incubated in 0.3% H2O2 for 30 minutes 
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to block endogenous peroxidase activity. Slides were washed with 1X PBS for 5 minutes and 
then incubated at room temperature with diluted blocking serum, which prevents non-specific 
binding, for 20 minutes. The primary antibody, rabbit anti-Tuberin polyclonal antibody (Santa 
Cruz; #sc-893) was administered to the sections on the slides. The slides were then left at 26
◦
C in 
a humidity chamber for approximately one hour or left at 4
◦
C overnight. The slides were washed 
again with 1X PBS for 10 minutes. The secondary antibody was administered to the slides at 
room temperature for one hour. This was followed by washing in 1X PBS for 10 minutes. The 
negative control slides were lacking the primary antibody. 
At the final stages of staining, DAB, 3,3-Diaminobenzidine substrate solution (Vector 
Laboratories, PK 61010) with H2O2 was used to incubate the slides after the wash in 1X PBS 
solution for about 30 seconds to 1 minute. Once a brown colour appeared, the slide was placed in 
1X PBS in order to stop the reaction and to obtain adequate staining. Sequentially, the sections 
were dehydrated by submerging them through an ethanol gradient of 70% ethanol, 95% ethanol, 
and 100% ethanol; followed by submersion in xylene to clear the tissue samples. The slides were 
placed in each gradient for approximately 10 minutes. Slides were mounted using Permount and 
then coverslips were applied to the slides.  
Leica CTR 6500 microscope was used to obtain pictures of the stained sections using the 
DFC 425 digital colour camera. Paxinos and Franklin’s mouse brain atlas was used to identify 
anatomical features of the brain
93
. The two main regions that were examined for embryonic time 
points ED 14.5 and ED 16.5, were the purkinje cell layer, and choroid plexus. The cerebellum 
was the structure of main focus in the postnatal brain samples. The pictures of the regions were 
taken at the following objectives; 2.5x, 10x, 20x and 40 x. 
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V. Immunohistochemistry (IHC): Quantification and Analysis 
Three sections of each sample were quantified using the program ImageJ. A gradient of black 
and white was used to calibrate the program with white selected as the background colour on the 
‘step tablet’ with a range of 0-250, 250 therefore representing the lightest staining. 
Representative sections were selected for the background (white region – designated as 250), and 
the darkest stained region (set to 0). Specific brain regions were compared on this scale by using 
the “free hand tool” to manually outline the region in the brain. Values that were obtained from 
control slides were subtracted from the slides containing secondary antibody. This difference 
reflects the difference in optic density between the control stained sections and the primary 
antibody stained sections. 
VI. Immunofluorescence and Analysis 
Sections were washed with 1X PBS for 5 minutes. Excess PBS was dried with kim wipes and 
the sections were outlined with a grease pen to prevent the antibodies from mixing and 
overflowing the sections. A solution consisting of 0.2% Triton diluted in 1X PBS was used to 
wash the sections for 5 minutes in order to permeabilize the tissue. Following this, the slides 
were washed in 1X PBS for 5 minutes. Consequently, the slides were incubated in LAP blocker  
(500 μL of Triton x-100, 0.75g glycine, 1.25 mL FBS, up to 50 mL 1X PBS) for 15 minutes 
before applying the primary antibodies to the sections in order to prevent nonspecific binding of 
antibodies (Muller et al, 2009). After taking off the excess LAP blocker, the rabbit anti-Tuberin 
polyclonal antibody (Santa Cruz Biotechnology; # sc-893) was diluted in the blocking serum 
with 1:250 μL ratio. The sections were left to incubate in the primary antibody at 4°C overnight. 
The control slides were treated only with the primary antibody and cover slipped the same day.  
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The next day, 1X PBS was used to wash the sections from primary antibody residue three 
times, 5 minutes each. Then secondary antibody was applied to the sections for 30 minutes. The 
secondary antibody consisted of 500 μL of LAP blocking serum, 1 μL of Alexa Fluor-488  goat 
anti-Rabbit dye (ThermoFischer Scientific; #1705869) and 1 μL of Hoechst (ThemoFischer 
Scientific; #62249). Due to Hoechst solution’s sensitivity to light, sections and secondary 
antibody, Texas Red goat anti-mouse (Life Technologies; 1666400) were covered in aluminum 
foil at all times. The slides were washed again with 1X PBS and cover slipped with anti-fade 
mounting solution. The light sensitive slides were then stored in an opaque box . 
Leica CTR 6500 microscope was used to obtain pictures of the stained sections using the 
FX360 digital colour camera for better resolution. Leica Application Suite (LAS) AF was the 
software that was utilized to view fluorescent images. As previously mentioned, the two main 
regions that were examined were the purkinje cell layer, the choroid plexus, and the cerebellum. 
The DAPI filter was used to look at the Hoescht stained nuclei of the cells. The GFP filter was 
used to detect the green dye, Alexa Fluor 488, for the Tuberin expression for 
immunofluorescence staining. Sections were imaged at 2.5X, 10X, 20X and 40X objectives. 
VII.  Primary cerebellum Tissue and Cell Extraction from Balb/c Mice 
To begin the tissue extraction procedure, the working station must be sterilized and the 
dissection equipment must be autoclaved. The mice were first euthanized using a CO2 chamber. 
The mouse head was swabbed with 95% ethanol and an incision across the midline of the skin 
and along the skull was made. In order to be able to expose the skull, the skin was pulled and cut 
underneath the ears to ease the process of tissue extraction. The skull was peeled off with sharp 
point forceps carefully without damaging the brain tissue under it. All connections to the brain 
such as the spinal cord and blood vessels were cut by picking up the brain from the base with 
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forceps. The brain was placed in a 60mm cell culture tissue dish (Sarstedt AG & Co.; #83.1801) 
and washed in DMEM media (Sigma Aldrich; # D5796) containing 3% penicillin and 
streptomycin (Gibco; #1540) for 2 minutes on a shaker. 
All steps following this were carried on in a laminar flow hood. In order to extract the cells, 
the cerebellum tissue must be diced into 1mm
3
 pieces using a scalpel blade no. 11. Once, the 
tissue was minced, it was transferred into a 15mL round bottom tube with DMEM media 
(Sigma-Aldrich; #D5796). The tissue was triturated using a Pasteur pipette by pipetting up and 
down gently and cells were spun at 250g for 1 min. The supernatant was removed and 1 mL of 
0.05% Trypsin (HyClone; #SH3023601) was added. The tube containing the cells was placed in 
a 37°C water-bath for 5 minutes. The cells were triturated again and DMEM media was added to 
inactivate the digestive ability of the Trypsin. The cells were centrifuged at 250g for 5 min and 
the supernatant was removed, and 2 mL media consisting of 10% FBS was added and the tube 
was spun for 5 min at 500g. The supernatant was discarded and the cells were dissociated into 
Neurobasal media (Thermo Fischer Scientific; # 21103-049) with B27 (Thermo Fischer 
Scientific; # B27), 20ng/ml EGF, and 10ng/ml FGF supplements (Thermo Fischer Scientific; # 
B27). The cells were then plated onto low adherent 6-well cell culture plates (Corning; #3471) at 
a density of 5 x 10
4
. The cells were monitored and media was replenished every three days. Once 
the cells start forming neurospheres, they can be collected and plated on adherent 6-well 
attachment plates and can be used for differentiation assay experiments. The neurosphere 
formation assay protocol was previously established by Pacey et al. (2006).  
VIII. Cell Culture: Primary Cerebellum Cells Assays 
Primary cerebellum cells were maintained in serum free Neurobasal Medium supplemented 
with B27, 20ng/ml  EGF (Gibco; #12483) and 10ng/ml EGF (Sigma; #1540). The cells were 
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seeded at 5x10
4 
cells per well in an ultra low attachment 6-well plate (Corning; #3471).  Cells 
were incubated at 37°C in 5% CO2. Every 5-10 days the primary neurospheres that formed were 
subcultured using 1 mL 0.05% Trypsin to detach the cells (HyClone; #SH3023601).  Once the 
subcultured primary sphere cells were needed for differentiation assays, the cells were provided 
with medium supplemented with 2% Fetal Bovine Serum (FBS) (Gibco; #12483). To harvest 
primary, and secondary neurospheres, the cells were seeded at 10000 cells per well in the ultra-
low attachment plates. Fresh media was added to the plate every 2-3 days to enrich the most 
stem-like population of cells. All samples were collected by centrifugation at 1000 rpm for 5 
min.   
IX. Cell Culture: DAOY Cell Line Neurosphere Assays  
The DAOY cells were seeded at 5x10
6  
cells per well in a 10 cm cell culture plate. They were 
incubated at 37°C in 5% CO2 and maintained in EMEM media supplemented with 10% FBS and 
1% penicillin and streptomycin until they reached 80% confluency. To grow cells in 
neurospheres, cells were subcultured onto low adherent 6-well plates and supplied with 
neurobasal media and growth factors B27, 20ng/ mL FGF, and 10ng/ mL EGF to enhance 
neurosphere formation. Once neursopheres were formed, they were subcultured into secondary 
neurospheres using 0.1 mM EDTA to dissociate the cells. A subset of the DAOY cells were 
treated with 250 ng/mL of Rapamycin and were then grown into neurospheres. The neurosphere 
numbers were counted using the Leica M205 FA fluorescence stereo microscope.  
X. Lentivirus Production 
Tuberin knock-down vector (pLKO.1. shTSC2) was obtained through (Addgene; # 15478). 
The production of the VSV-F pseudo typed lentivirus was executed by a HEK293 LentiX cells 
transient transfection. The transfection was performed with the specific plasmid along with 
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pMDG, pMDL2, and pRSV packaging plasmids with the aid of Polyethylenimine (PEI) (Sigma 
Aldrich, # 408719) in a DNA to PEI ratio of 1:3. This was followed by incubation in 5% CO2 at 
37°C for 5 hours. The following day, virus collection was performed and through 
ultracentrifugation, the collected virus was concentrated at 4ºC for 3 hours. Viral titer 
determination was done by 293T cells transduction. This process was followed by flow 
cytometry analysis of eGFP protein expression at 72 hours after transduction. The titred virus 
was filter sterilized and stored at -80°C. 
XI. Cell Culture: DAOY Cell Line Tuberin knock down  
For Tuberin knock down experiments using DAOY cell line, the cells were subcultured in 
96- well plates with 100 μl EMEM media without antibiotics or serum overnight and 10μg/mL of 
polybrene (Santa Cruz sc-134220) was added. 1 μl of shTSC2 virus was then added per well. A 
subset of cells were treated in the same way with the scrambled sequence vector, PLKO.1, as a 
control. The following day, the media was removed and cells were washed with 1X PBS and 
then fresh media containing 2 μg/ mL puromycin (Sigma-Aldrich; #P8833) was added in order to 
select for cells that have been successfully infected. After giving the cells 1-2 days recovery 
time; they were then used for experimental assays. 
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Table 1: Established Cell Lines 
Cell line Source Disease Tissue 
Primary Cerebellum 
Cells 
Primary Extraction 
from PN 4 Mouse 
Cerebellum. 
None Brain/ cerebellum 
DAOY- HTB-186 ATCC Desmoplastic 
Medulloblastoma 
Brain/ cerebellum 
 
XII. Cell Surface Marker Analysis: Flow Cytometry 
As previously described, DAOY cells were treated, cultured and collected. Cells were 
centrifuged and cell pellets were collected to prepare for flow cytometry experiments. For every 
sample, 5x10
6 
cells were stained with rabbit anti-Tuberin polyclonal primary antibody and 
Alexa488 rabbit secondary antibody. In addition, cells were labeled for CD133 using CD133/ 
Allophycocyanin (APC) antibody (eBioscience; #17-1338-42). Cells were left to incubate on ice 
for 45 min in the dark.  Some samples were double labeled with TSC2 and CD133. BD 
Biosciences Flow Cytometry Transcription Factor Set was used to perform the staining 
procedure (Pharmingen; # 562574).  Once the incubation period was over, the cells were spun at 
250g for 5 minutes, washed 2 times with PBS. Cold 1xPBS is used to re-suspend the cell pellets. 
Samples were analyzed using the BD LSR Fortessa X-20 cell Analyzer. 
XIII.  Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)  
RNA was extracted from samples using an RNeasy Extraction Plus Mini Kit (Qiagen; 
#74134) as per manufacturer’s protocol. A NanoDrop Spectrophotometer (ND-1000 software 
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version 3.3.0, Thermo Scientific) was used to measure the concentration and check the purity of 
the obtained samples. The obtained RNA samples were stored at -80ºC until needed for cDNA 
synthesis. Superscript II reverse transcriptase (Invitrogen; #100004925) was used to convert 
RNA to cDNA. ABI Viia7 thermocycler (Applied Biosystems; #278880504) was used to carry 
out qrt-PCR with Fast SYBR green to detect gene expression levels. The reaction was run for the 
length of 45 cycles. The primers that were used were specific for each cell type with GAPDH 
being the internal control at a concentration of 5μM. Specific primers are listed in Table 2 and 
Table 3. Obtained PCR results were reported as CT values that are relative to GAPDH. Further 
data analysis was carried out using Microsoft Excel and the final results are represented as log10 
RQ or RQ Values.  
 Table 2: Mouse Oligonucleotide Primers 
Mouse  
Gene 
Forward Primer (5’-3’) Reverse Primer (5’-3’) 
GAPDH GCACCGTCAAGGCTGAGAAC GGATCTCGCTCCTGGAAGATG 
TSC2 TTGTGAGGAGGTTATGGCCATT GCAGCTGAACTTCATCTCTGTTGTAG 
 
Nestin ACCTATGTCTGAGGCTCCCTATCCTA ACCTATGTCTGAGGCTCCCTATCCTA 
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Table 3: Human Oligonucleotide Primers 
Human Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
GAPDH GCACCGTCAAGGCTGAGAAC  
 
GGATCTCGCTCCTGGAAGATG 
TSC2 GAGAGGAGCCGTGTTTTTTGTG GACATGCCATGGCCTGGTA 
CD133 CAATGACCCTCTGTGCTTGGT GTGGAAGCTGCCTCAGTTCAG 
Nestin AGAGGGGAATTCCTGGAG CTGAGGACCAGGACTCTCTA 
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RESULTS 
I. Tuberin Protein Levels Vary Across Different Regions of the Mammalian Brain 
To begin to determine when and where Tuberin protein is expressed across the brain a 
specific focus on regions related to cerebellum development and general stemness 
characteristics in the brain were investigated. Brain regions such as the olfactory bulb and 
cerebral cortex were quantified and compared to the purkinje cell layer and choroid plexus, 
which are the two regions of interest (Figure 5 A, B). These regions actively undergo 
neurogenesis during embryonic development. Tuberin protein levels in each region were 
compared at ED 14.5, and ED 16.5, respectively. The brain tissue was sectioned in the 
sagittal plane and was treated with Tuberin primary antibody and DAB stain using 
Immunohistochemistry technique (Figure 5 C, D).  The levels of Tuberin expression seemed 
to vary throughout the brain regions. 
To determine how levels of Tuberin change over different time points in different regions 
of the brain we first compared the trend of expression in the cerebral cortex (Figure 6). 
Tuberin protein level intensities between the cerebral cortex at ED 14.5 and ED16.5 were not 
significantly different hence the cerebral cortex represents a good control between these time 
points (Figure 6A-C). As seen with the cerebral cortex, there was no significant change in 
Tuberin protein levels in the olfactory bulb between ED 14.5 and ED 16.5 (Figure 7A-C). 
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Figure 5. Tuberin Protein Levels at ED 14.5 and ED 16.5 in Different Regions of the Brain. 
Immunohistochemistry was performed using Tuberin primary antibody. (A) A control image of 
the full brain lacking the primary antibody. (B) Full brain image at 2.5x objective showing all the 
brain regions; Purkinje Cell layer (PCL), Choroid Plexus (CP), and Cerebral Cortex (CC). Scale 
bar 1mm (C) & (D) Tuberin protein levels at ED 14.5 and ED 16.5. The y-axis represents the 
difference in optic density of the DAB stain which ranges from 0-250 with 0 value representing 
the lighter DAB stain. The x-axis shows the brain regions; Purkinje Cell Layer, Choroid Plexus, 
Olfactory bulb, and Cerebral Cortex, that were analyzed.   
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Figure 6. Depiction of Tuberin Protein Levels at ED 14.5 and ED 16.5 in the Cerebral 
Cortex. 
Immunohistochemistry was performed using Tuberin primary antibody. (A) A control image of 
the cerebral cortex lacking the primary antibody at ED 14.5 and ED 16.5 at 10x objective 
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showing scale bar 200µm. (B) Image of cerebral cortex treated with Tuberin primary antibody at 
ED 14.5 and ED 16.5. (C) Tuberin protein levels quantified at ED 14.5 and ED 16.5. The y-axis 
represents the difference in optic density of the DAB stain ranging from 0-250 with 0 value 
representing the lighter DAB stain. The error bars represent the SEM over 9 (N=9) individual 
experiments. Statistical analysis was performed using single factor ANOVA. p> 0.05. 
 
 
Figure 7. Tuberin Protein Levels at ED 14.5 and ED 16.5 in the Olfactory Bulb. 
Immunohistochemistry was performed using Tuberin primary antibody. (A) A control image of 
the cerebral cortex lacking the primary antibody at ED 14.5 and ED 16.5 at 10x objective 
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showing scale bar 200µm. (B) Image of cerebral cortex treated with Tuberin primary antibody at 
ED 14.5 and ED 16.5. (C) Tuberin protein levels quantified at ED 14.5 and ED 16.5. The y-axis 
represents the difference in optic density of the DAB stain ranging from 0-250 with 0 value 
representing the lighter DAB stain. The error bars represent the SEM over 9 (N=9) individual 
experiments. Statistical analysis was performed using single factor ANOVA. p> 0.05. 
 
Tuberin Protein Levels are Regulated in Certain Regions of the Brain 
The choroid plexus and purkinje cell layer are brain regions that mark the beginning of the 
formation of the cerebellum during embryonic development. The choroid plexus was examined 
to assess Tuberin protein levels. The choroid plexus is made up of specialized cells that are 
located in the brain’s ventricles. These ventricles are characterized by the production of the 
cerebrospinal fluid. Furthermore, this structure provides the brain with immunological and 
physical protection by having a blood brain barrier
94
. Immunohistochemistry was performed to 
determine the levels of Tuberin in the choroid plexus at ED 14.5 and ED 16.5. Control slides 
were lacking the primary antibody (Figure 8A). Sections at ED 14.5 and ED 16.5 were treated 
with both primary and secondary antibody (Figure 8B). There was no significant change in 
Tuberin protein levels in the choroid plexus between embryonic development time points, 
p>0.05 (Figure 8C). 
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Figure 8. Tuberin Protein Levels at ED 14.5 and ED 16.5 in the Choroid Plexus. 
Immunohistochemistry was performed using Tuberin primary antibody. The y-axis represents 
the difference in optic density of the DAB stain which ranges from 0-250 with 0 value 
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representing the lighter DAB stain. The x-axis shows the brain region comparing ED 14.5 and 
ED 16.5. (A) A control image of the choroid plexus lacking the primary antibody at ED 14.5 and 
ED 16.5 at 10x objective showing scale bar 200µm. (B) Image of choroid plexus treated with 
secondary antibody at ED 14.5 and ED 16.5. (C) Graph comparing Tuberin protein levels at ED 
14.5 and ED 16.5 in the choroid plexus. Error bars represent SEM over 9 (N=9) individual 
experiments. Statistical analysis was performed using single factor ANOVA. p> 0.05. 
 
The purkinje cell layer forms the middle layer of the cerebellum which is crucial for motor 
control and coordination. Purkinje cells house vital neurons that are important in the cerebellar 
cortex and contain some of the largest neurons in the brain
95
. Brain tissue was sectioned and 
controls (secondary antibody only) were obtained for both ED 14.5 and ED 16.5 (Figure 9A). 
Images for sections treated with both primary and secondary antibodies were obtained at 10x 
objective for both time points (Figure 9B). Tuberin protein levels were found to significantly 
increase in the purkinje cell layer at the later time point during embryonic development, p< 0.05 
(Figure 9C).  
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Figure 9. Tuberin Protein Levels at ED 14.5 and ED 16.5 in the Purkinje Cell Layer. 
Immunohistochemistry staining was performed using Tuberin primary antibody. (A) A control 
image of the choroid plexus lacking the primary antibody at ED 14.5 and ED 16.5 at 10x 
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magnification showing scale bar 200µm. (B) Image of purkinje cell layer treated with secondary 
antibody at ED 14.5 and ED 16.5. (C) Graph comparing Tuberin protein levels at ED 14.5 and 
ED 16.5 in the purkinje cell layer.  Tuberin levels decreased at ED 16.5 as compared to ED 14.5. 
The y-axis represents the difference in optic density of the DAB stain which ranges from 0-250 
with 0 value representing the lighter DAB stain. The x-axis shows the brain region comparing 
ED 14.5 and ED 16.5. Error bars represent the SEM for 9 (N=9) individual experiments. 
Statistical analysis was performed using single factor ANOVA. *p< 0.05.  
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II. Tuberin mRNA Levels are Regulated during Differentiation and Cell Fate 
Decisions 
To determine endogenous Tuberin mRNA levels in the mouse cerebellum and in stem-
like or progenitor cell populations, primary mouse cerebellar cells were extracted and 
differentiated in vitro, and collected for qrt- PCR analysis.  The samples were run in a qrt-PCR 
reaction. Nestin, a stemness marker, was used as a control to verify that the subpopulation of 
cells is representative of the stem and/or progenitor population
56
. First, an early differentiation 
time course, 0-24 hours, was investigated. In this time course, no significant pattern was seen for 
samples run with Nestin (Figure 10A) or Tuberin (Figure 10B). The constant levels of Nestin 
indicate that the cells were not differentiating during this time course. The cells were observed 
under the microscope and no cellular dendrite extensions were formed at the end of the 24 hours 
differentiation time point; therefore, a longer differentiation time course was carried out.  
After a 72 hours differentiation time course, it was verified that the cells had been 
differentiated which was indicated by the decrease in Nestin expression from 0-72 hours (Figure 
11A). Interestingly, Tuberin mRNA levels also seemed to follow an overall pattern of decreasing 
as the cells were differentiating (Figure 11B). This result, although not statistically significant, 
may suggest the possibility of Tuberin’s role in regulating stem cell fate decisions in the normal 
brain especially at early time points of development.               
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Differentiation Time Points
Differentiation Time Points  
Figure 10. Tuberin mRNA Levels Follow a Decreasing Pattern at Early Stages of 
Differentiation  
mRNA analysis of primary cerebellum cells, post-natal day 4, that were differentiated over 24 
hours. (A) Nestin mRNA levels were measured using qrt-PCR analysis where data is normalized 
to GAPDH and data is reported as relative quantification values (RQ). The y-axis represents 
A 
B 
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Nestin expression levels. (B) Tuberin mRNA levels reported as RQ over 24 hours time course 
for three independent experiments. The y-axis represents Tuberin expression levels. Error bars 
indicate SEM of three independent qrt- PCR experiments ran in triplicate. mRNA levels are 
normalized against 0 time point. p> 0.05. Statistical analysis was done one-way ANOVA.  
 
Figure 11. Tuberin mRNA Levels are Regulated throughout Differentiation  
mRNA analysis of primary cerebellum cells, post-natal day 4, differentiated over 72 hours (A). 
Nestin mRNA levels normalized to GAPDH and reported as relative quantification value (RQ).  
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(B) Tuberin mRNA levels reported as RQ over 0-72 hours time course for three independent 
experiments. Error bars indicate SEM of three independent qrt-PCR experiments ran in triplicate. 
mRNA levels are normalized against 0 time point. p> 0.05. Statistical analysis was done one-
way ANOVA.  
III. Tuberin Expression Increases in the Stem Cell Population in the DAOY Cell 
Line  
Using the Medulloblastoma cell line, DAOY, primary and secondary neurospheres were 
allowed to form under stem cell conditions (Figure 12A). To look at whether Tuberin expression 
correlates with the tumour stem cell marker CD133, levels of Tuberin were analyzed in the 
CD133 positive population (CD133
+
) using flow cytometry. Neurospheres were dissociated and 
cells were stained with Tuberin-Alexa 488 and CD133-Allophycocyanin (APC) antibodies, 
DAOY cells grown in monolayer were used as a negative control for the stem-cell population. In 
the monolayer, the population of cells positive for CD133 was close to 0% indicating that the 
stem cell population at that point was very minimal. In the primary neurosphere population, 
CD133 cell percentage was approximately 18% and the percentage of cells that were labeled for 
both TSC2
+
/ CD133
+
 was about 7%. This percentage increased in the secondary neurosphere 
population to 18% (Figure 12B). 16% of the cells in the secondary neurospheres remained 
positive for CD133 alone. In addition, looking at the percentage of cells that were TSC2
-
/ 
CD133
-
, one can see that this population declines as the cells are selected for the more stem-like 
populations in the secondary neurosphere conditions. These findings suggest that Tuberin is 
selectively present in stem cell populations, whether Tuberin plays a functional role in cell fate 
decisions is an intriguing possibility.  
A similar flow cytometry analysis was conducted to investigate the percentage of stem-
like cells that were positive for Tuberin along with CD133 in DAOY cells that were manipulated 
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in vitro. DAOY secondary neurospheres were treated with the mTOR inhibitor Rapamycin or 
were infected with a PLKO-shTSC2 lentiviral vector targeted against Tuberin mRNA. 
Neurospheres lacking Rapamycin treatment and TSC2 knock-down, were used as controls. It 
was observed that the percentage of Tuberin
+
 and Tuberin
+
/CD133
+
 labeled cells, significantly 
decreased when Rapamycin was added to the neurospheres, this effect was even more 
pronounced in the secondary neurospheres (Figure 12C).  
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Figure 12. Flow Cytometry Analysis of CD133 and Tuberin Expression in DAOY 
Neurospheres  
DAOY cells were allowed to form primary and secondary neurospheres. The neurospheres were 
stained with Tuberin and CD133 antibodies. (A) Representative images of primary and 
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secondary DAOY neurosphere growth under necessary growth supplements. Scale bars = 20 
pixels  (B) Flow cytometry results reported as percentage of cells stained for Tuberin
+
, CD133
+
 
and Tuberin
+
/CD133
+
. (C) Percentage of secondary neurospheres staining for Tuberin
+
, and 
Tuberin
+
/ CD133
+
 after treating with Rapamycin and shTSC2. Error bars represent SEM. 
Unpaired student’s t-test. *p< 0.05.    
 
TSC2 Knock-Down Affects Primary Neurosphere Formation 
 To test the functional importance of Tuberin in neurosphere formation, DAOY cells were 
seeded into stem-like conditions needed for neurosphere formation and the effects of Rapamycin 
treatment and Tuberin knock-down, were monitored. Rapamycin treatment did not statistically 
reduce overall neurosphere numbers (Figure 13A). However, when Tuberin was knocked-down, 
the number of neurospheres formed significantly decreased (Figure 13B).  
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Figure 13. Tuberin Knock-down Decreases the Number of Primary Neurospheres. 
DAOY cell(A) neurospheres were treated with vehicle control (w/o Rapamycin) and(B) TSC2 
knock- down.  Error bars represent SEM of three independent experiments. Statistical analysis 
done using student’s t- test. * p< 0.05. 
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TSC2 Knock-Down Affects Secondary Neurosphere Formation 
 To elucidate a functional role for Tuberin on Neurosphere self-renewal, primary 
neurospheres treated with Rapamycin or shRNA to knock-down Tuberin and then subcultured 
and seeded into secondary neurosphere formation assays where the number of neurospheres was 
counted over time. Secondary neurospheres that formed were counted at 4 days, 6 days, and 8 
days, respectively. Rapamycin treatment had no statistically significant effect on self-renewal 
across the six replicates (Figure 14A). Tuberin knock-down resulted in a significant decrease in 
the number of secondary neurospheres that formed by day 8 (Figure 14B). 
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Figure 14. Secondary Neurosphere formation is impaired in the absence to Tuberin. 
DAOY cells were subcultured and plated for secondary sphere formation after treatment with 
(A) 250 ng/mL of Rapamycin or vehicle control (w/o Rapamycin) or (B) scrambled shControl or 
shTSC2.  Total number of neurospheres are recorded on Y axis over the indicated timepoints. 
Error bars indicate SEM over six independent experiments. Student’s t- test was conducted. * p< 
0.05. 
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DISCUSSION 
Cell growth and proliferation are essential for normal development but must be tightly 
regulated to prevent tumours from forming 
97
. This represents a particular challenge during early 
development when cell growth and proliferation are occurring very rapidly. Childhood cancers, 
such as those that affect the brain and the blood occur due to an inability to restrict the growth of 
select cell populations. Today, we know a great deal about specific DNA mutations and deletions 
that are associated with a plethora of overgrowth disorders; however, proposing suitable 
treatments for these disorders requires a complete understanding of how these changes impact 
growth and development. This thesis focuses on resolving some of the biology around the 
protein Tuberin that is mutated in a number of human tumours, including those found in select 
childhood brain tumours.  
Mutations in the gene encoding Tuberin, TSC2, are the most prominent alteration in 
benign tumours, known as hamartomas, which can form in many organs in the body including 
the brain
98
. TSC2 mutations are also found in select brain cancers such as giant cell 
astrocytoma
99
. In combination with other mutations such as those in the Sonic HedgeHog (Shh) 
pathway, Tuberin mutations enhance the prevalence of the childhood brain cancer 
Medulloblastoma (MB)
88
. Understanding how Tuberin regulates the growth of neural cell 
populations may point to therapeutic directions that can benefit patients with these diseases.  
Mechanistically, Tuberin is most noted for its roles as a heterodimer with the protein Hamartin, 
referred to as the Tuberous Sclerosis Complex (TSC) 
8
. 
 The most well established role of the TSC is as a negative regulator of the Mammalian 
Target of Rapamycin (mTOR)
100
. mTOR is highly conserved and it is involved in a plethora of 
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cellular processes but is most noted for controlling protein synthesis 
101
. Hence the most obvious 
role of a Tuberin mutation would be to encourage cell overgrowth via a lack of control over 
protein synthesis and depleting the tumour suppressor roles of Tuberin on the cell cycle. These 
functions are likely the major drivers of several of the benign hamartomas that form in TSC2 
mutated patients. However, astrocytoma and MB are aggressive malignant brain cancers driven 
at least in part by an aggressive population of cells that harbor stem-like properties. These cells 
are termed cancer stem cells, which are capable of giving rise to different cell types within the 
tumour
64
. While cancer stem cell populations may not arise from mutations occurring in normal 
stem cells, they evolve to possess many of the qualities of a normal stem cell including the 
ability to self renew. Previous studies done by Kobayashi et. al. in 1996, have shown that TSC2 
knock-out mice died at ED 10 due to failure of neural tube closure, suggesting the intriguing 
possibility that Tuberin may have an active and essential role in the early stages of brain 
development
102
. One of the key objectives of this work was to determine where and when 
endogenous Tuberin was found in the developing brain. Should Tuberin play an essential role in 
neuro- or gliogenesis, we hypothesized that protein levels may be elevated at earlier stages of 
embryonic development. We focused primarily on the structures that give rise to the cerebellum 
given that this is the region of the brain where MB is derived.    
To study normal protein expression in a tissue specific manner in a Balb/C mouse model, 
IHC staining in cerebellum forming regions, such as the choroid plexus and purkinje cell layer 
was performed. No significant differences in Tuberin protein levels were observed when 
comparing various regions of the brain (olfactory bulb, cerebral cortex, choroid plexus, and 
purkinje cell layer) within a given developmental time point. However, when protein levels 
within the regions were compared between time points, it was observed that Tuberin protein 
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levels significantly increased in the purkinje cell layer at ED 16.5. This suggests that between 
these two critical time points of development and cell fate determination, Tuberin expression is 
being regulated. How this is related to neurogenesis within this region requires further dissection 
of the numbers of relative cell populations at ED 14.5 and 16.5 in this particular brain region, 
and a close up study of the specific stem/progenitor staining for Tuberin. It is possible that the 
most stem like and/or progenitor population might be increasing or proliferating at this time to 
give rise to the different distinct layers of the cerebellum. It is documented in a study by Murthy 
et. al. in 2001., that Tuberin expression is relatively high in the brain during brain development 
especially starting at ED13
103
. Conversely, Tuberin levels were decreasing in other organs in the 
body including the kidneys, liver, and heart
103
. In these organs, it is possible that the cells were 
terminally differentiated; therefore, these cells do not need a high level of Tuberin to keep 
cellular proliferation and growth under control. This may shed light on the significance of 
Tuberin in regulating growth in mammalian brain development at early embryonic time points 
especially during neurogenesis.  
The increased protein levels of Tuberin observed in the purkinje cell layer may be an 
indication of its regulatory role in cellular growth especially in the neural stem cells. This tumour 
suppressor protein may be allowing for cellular proliferation and preventing neural cell 
differentiation at this time. Tuberin might be needed to instantly increase at a certain stage in 
development to regulate the proliferation and differentiation process. Analyzing normal Tuberin 
levels within the purkinje cell layer is important because neurological disorders, such as Autism 
Spectrum Disorders (ASDs), tend to arise in the purkinje cells of the cerebellum due to TSC2 
mutations
95
. In a recent study, it was found that  loss of TSC2 in the purkinje cells is linked to 
neurological disorders
95
. This provides evidence for the importance of Tuberin in this region.  
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The purkinje cell layer arises from the granular precursor neurons in the cerebellum. 
Those neurons migrate from the granule cell layer, give rise to the purkinje cell layer, and 
eventually give rise to the molecular layer
104
. We speculate that these granule cells possess stem 
cell properties and, as they differentiate, they give rise to purkinje cells. Once the purkinje cell 
layer is formed, Tuberin levels decrease, supporting the hypothesis that Tuberin is required early 
in development and that Tuberin has a role in regulating both cell growth and differentiation. 
Further research would be required to specifically mark the purkinje cells and look at normal 
Tuberin levels at the cell level rather than the tissue as a whole.  
In preliminary experiments (Appendix A Figure 1), the purkinje cell layer and choroid 
plexus were stained with stem cell protein markers, such as Pax6. Pax6 is expressed in stem cells 
that have not yet differentiated 
105
. Those brain sections were co-stained with Tuberin to assess 
Tuberin co-localization with Pax6 in the stem cell population. Our early data suggests that 
Tuberin is expressed in the same region as Pax6 expression in the purkinje cell layer. This 
preliminary result might indicate that in fact Tuberin is expressed in stem cells where it could be 
playing a role in maintaining that population and regulating differentiation, proliferation, and 
overall cell fate. Further investigation would require high magnification analysis of each cell to 
fully observe Tuberin and Pax6 expression together. 
Future experiments, utilizing lineage tracing would be extremely useful in assessing 
Tuberin localization within the neural stem cell population during cerebellum developmental 
stages. One can label the cell of interest, the granule cell, with a fluorescent protein, which would 
be Tuberin, and track its differentiation status in the tissue. Tissue harvesting and sectioning at 
ED 14.5 and ED 16.5 could be undergone and staining with an antibody against Tuberin would 
reveal Tuberin expression; identifying if Tuberin is present within these neural stem cells. In 
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addition, it will be easily observed whether Tuberin is important to maintain homeostasis of the 
neural stem cell population. 
  Interestingly, regulation by Tuberin in the regions that give rise to the cerebellum may 
imply its importance in MB, given that MB tumours arise in the cerebellum 
88
. MB arises from a 
subpopulation with cancer stem cell properties 
63
. Hence we optimized the isolation of primary 
mouse cerebellum cells to study the importance of Tuberin during cell fate and differentiation 
decisions. In a short time course of differentiation (24 hours), no significant change in Tuberin 
expression was identified however, over a 4 day differentiation time course the mRNA levels of 
Tuberin significantly decreased over time. This supports the hypothesis that Tuberin is needed 
early on before differentiation in the stem cell or progenitor population to regulate cellular 
growth and differentiation. Tuberin expression decrease would facilitate an increase in protein 
synthesis, allowing for the production of specialty proteins needed for fully functional 
differentiation. To further validate this hypothesis, experiments involving Tuberin over-
expression in cerebellum cells would be required.  It has been previously established that 
Tuberin interacts with a variety of pathways that guide and regulate cell fate and differentiation. 
In a study of neuroepithelial progenitor cells from TSC2 homozygous null mice, cells cultured 
from ED 10.5 had abnormal cell differentiation
106
. In a separate study, Tuberin knock-down 
prohibited proper axon formation in actively developing neurons. In the cerebellum, an increase 
in proliferation of the neural precursor cells and a decrease in neuron outgrowth were reported
34
. 
To further support the regulatory role of Tuberin in these key cellular events, it has been noted 
by a group of researchers that diseases caused by Tuberin mutations are linked to abnormal 
differentiation, further supporting the involvement of Tuberin in the regulation of cell fate and 
differentiation 
34
.    
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To investigate the effects of Tuberin on stemness properties, primary extracted cerebellum 
cells were exposed to lentiviral Tuberin knock-down. Preliminary results from a neurosphere 
formation assay, showed that neurosphere size increased (Appendix A Figure 2). This result 
supports that the loss of the tumour suppressor protein causes uncontrollable division, whether 
the increased size is due to proliferation of select populations or truly through an increase in self-
renewal needs to be further explored using secondary neurosphere forming assays and cell pair 
assays.  
CD133 has been shown to be expressed in cancer stem cells. Using CD133 as the stem 
cell marker for the Shh derived Medulloblastoma cell-line, DAOY, cells were cultured under 
stem cell conditions promoting the formation of neurospheres
96
. Through the use of flow 
cytometry, the collected neurospheres were sorted from a single cell suspension and stained with 
specific antibodies. In the monolayer, the CD133
+ 
population was almost non-existent, which is 
expected since the cells at this stage are less stem-like. The CD133
+ 
cell population is expected 
to increase as the cells become more stem-like going from monolayer to primary and then 
secondary neurospheres. In comparison, the percentage of cells that were Tuberin
+
/CD133
+
 
increased as cells were passaged as neurospheres. This result indicates that Tuberin is present in 
the stem cell population, consistent with endogenous levels being elevated in select populations 
at earlier stages of development.  Whether Tuberin plays a direct role on the functional stem cell 
properties cannot be determined from this assay alone.  
To elucidate the role of Tuberin in the stem cell population, DAOY cells were 
manipulated by lentiviral infection to knock-down Tuberin. Cells infected with a lentiviral 
shRNA scrambled vector served as the control for the experiment. The percentage of cells that 
were Tuberin
+
/CD133
+ 
significantly decreased when compared to the control, as expected. There 
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were fewer neurospheres formed when Tuberin was knocked-down, providing good support that 
Tuberin is essential for the stem cell population self-renewal. Moreover, a group of cells were 
treated with Rapamycin, which halts mTOR activity and blocks protein synthesis/cell growth. 
Through experimental treatment of the cells with Rapamycin, it was observed that there is a 
decrease in the Tuberin
+
/ CD133
+
 population and a decrease in neurosphere numbers, confirming 
that mTOR regulation is necessary for the stem cell population of self renewal. Our neurosphere 
experiments confirm that Tuberin plays a critical role in the maintenance of the stem cell 
population; whether it is through self-renewal, survival or proliferation remains to be further 
determined. Rapamycin alone did not have a significant effect on neurosphere number which 
suggests that Tuberin role in stem-cell self-renewal is either not only mediated through mTOR, 
or that the appropriate stimulus was not provided for testing (ie. a differentiation stimuli). An 
experiment that could shed light on the mechanism of Tuberin function would be to treat cells 
that are Tuberin null with Rapamycin to determine whether the cells would be able to self-renew 
and proliferate or if Rapamycin would completely inhibit their growth with the lack of Tuberin 
in the cells.  
We assess self-renewal through secondary neurosphere formation in Tuberin null cells and 
Rapamycin treated cells. Over an 8 day period, there was a significant decrease in Tuberin in the 
secondary neurospheres. A decline in the number of neurospheres was also seen with Rapamycin 
treatment although findings were not statistically significant. This experiment, supports that 
Tuberin may be essential in regulating the stem cell population. When Tuberin is knocked-down, 
the cells start to die or growth is halted due to misregulation of the the mTOR regulatory 
pathway. To further enhance this result, investigating the activity of mTOR downstream 
effectors, such as S6K, would provide insight regarding the possible misregulation of mTOR. 
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Overall, this research emphasizes a potential role for Tuberin in regulating and 
maintaining the progenitor stem cell population. We have determined that Tuberin is present, and 
even elevated, in specific regions of the brain at early time points of development when 
neurogenesis is at its peak. Tuberin seems to be regulating the process of cell fate decisions in 
instances where it halts cell proliferation and allows for terminal cell differentiation. Assessing 
Tuberin levels in primary extracted cerebellum cells is one of the few studies that try to link 
Tuberin regulation with stem cell fate decisions. Being able to correlate Tuberin expression with 
tumour stem cells, such as those in MB cells, will help imply how these cancer stem cells are 
driving tumourogenesis. One of the limitations to working with primary extracted cerebellum 
cells is that they are short lived and extraction is both challenging and time consuming. New 
advances in technology such as the CRISPR/CAS9 tool, allows researchers to manipulate the 
genome. Therefore, CRISPR/CAS9 technology would enable us to determine the role of select 
TSC2 mutations in any cell type selected in the absence of endogenous wild-type protein.  This 
would enable us to find answers faster and more efficiently. The CRISPR/CAS9 system would 
also allow us to knock-in select TSC2 mutations in vivo. With the advent of this new exciting 
technology we can take the results obtained herein to a new level to determine whether Tuberin 
signaling has potential as a therapeutic target for select forms of tumour disorders.   
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Appendix A 
 
 
Figure 1. Tuberin and Pax6 are Expressed Around the Purkinje Cell Layer Area. 
Purkinje cell layer area at ED 16.5 was stained using Immunofluorescence. (A) Control section 
lacking the primary antibody and expressing DAPI nuclear stain. (B) Tuberin expression shown 
in red around the PCL. (C) Pax6 expression shown in red around the PCL. All images were 
taken with a 10x objective 
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Figure 2. Tuberin Knock-down in Primary Cerebellm Cells shows and Increase in 
Neurosphere Size 
Stem-like cells from the mouse cerebellum at PN=4 were stimulated to form neurospheres. (A) 
Image of neurospheres after shTSC2 control infection. (B) Cells treated with shTSC2 infection 
and (C) Cells treated with a different knock-down construct of shTSC2. Images were taken in 
bright field, GFP, and an overlay of both fields, respectively. Green fluorescence indicates 
successful knock-down. 
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